生长因子制剂疗法修复运动损伤的可行性
Feasibility of Growth Factor Agent Therapy in Repairing Motor Injury.
作者信息
Tan Qiaoyin, Li Jiayu, Liu Yuwen, Zhu Xiaojuan, Shao Weide
机构信息
College of Teacher Education, Zhejiang Normal University, Jinhua, China.
College of Physical Education and Health Sciences, Zhejiang Normal University, Jinhua, China.
出版信息
Front Pharmacol. 2022 Jan 25;13:842775. doi: 10.3389/fphar.2022.842775. eCollection 2022.
Growth factors (GF), with the activity of stimulating cell growth, play a significant role in biology, medicine, and exercise physiology. In the process of exercise, human tissues are impacted, making cells suffer damage. Growth factor can accelerate the repair of damaged cells and regulate the synthesis of protein, so biological preparations of growth factors can be added to traditional therapies. A combination of growth factor biologics and conventional therapies may improve the efficiency of injury repair, but growth factor biologics may not produce any results. The feasibility of growth factor biologics in the treatment of motor injury was discussed. The research have shown that: 1) GF biological agent therapy is a very promising treatment for motor injury, which is based on the power of autologous growth factor (GFs) to accelerate tissue healing, promote muscle regeneration, increase angiogenesis, reduce fibrosis, and make the muscle injury rapid recovery. 2) There are various methods for delivering the higher dose of GF to the injured tissue, but most of them depend on the platelet release of GF. At the site of injury, there are several ways to deliver higher doses of GF to the injured tissue. 3) At present, the inhibition of GF is mainly through signal transduction inhibitors and inhibition of transcription factor production. 4) Pattern of GF during wound repair: GF directly regulates many key steps of normal wound repair, including inflammatory cell chemotaxis, division and proliferation of fibroblasts, keratinocytes and vascular endothelial cells, formation of new blood vessels, and synthesis and degradation of intercellular substances. 5) When GF promotes chronic wound healing, in most cases, certain GF can be used targeted only when regulation still cannot meet the need for repair.
生长因子(GF)具有刺激细胞生长的活性,在生物学、医学和运动生理学中发挥着重要作用。在运动过程中,人体组织受到冲击,导致细胞受损。生长因子可以加速受损细胞的修复并调节蛋白质合成,因此生长因子的生物制剂可添加到传统疗法中。生长因子生物制剂与传统疗法相结合可能会提高损伤修复效率,但生长因子生物制剂可能不会产生任何效果。本文探讨了生长因子生物制剂在治疗运动损伤方面的可行性。研究表明:1)GF生物制剂疗法是一种非常有前景的运动损伤治疗方法,其基于自体生长因子(GFs)加速组织愈合、促进肌肉再生、增加血管生成、减少纤维化并使肌肉损伤快速恢复的能力。2)有多种方法可将更高剂量的GF递送至受损组织,但大多数方法依赖于血小板释放GF。在损伤部位,有几种方法可将更高剂量的GF递送至受损组织。3)目前,对GF的抑制主要通过信号转导抑制剂和抑制转录因子产生来实现。4)GF在伤口修复过程中的作用模式:GF直接调节正常伤口修复的许多关键步骤,包括炎性细胞趋化、成纤维细胞、角质形成细胞和血管内皮细胞的分裂与增殖、新血管形成以及细胞间物质的合成与降解。5)当GF促进慢性伤口愈合时,在大多数情况下,只有在调节仍无法满足修复需求时才可以靶向使用某些GF。
相似文献
Front Pharmacol. 2022-1-25
Acta Biomater. 2019-3-29
Chir Organi Mov. 2008-12
Br J Sports Med. 2012-11-29
Front Bioeng Biotechnol. 2023-9-14
J Control Release. 2021-4-10
ACS Appl Mater Interfaces. 2016-7-15
引用本文的文献
Front Pharmacol. 2022-10-13